血管危险因素与巨细胞动脉炎视力丧失的关联
基于国际血管炎诊断与分类标准研究,纳入26个国家433例巨细胞动脉炎(GCA)患者,分析诊断后6个月新发失明的发生率与决定因素。结果显示7.9%患者至少一眼失明,基线卒中(OR=4.47,95%CI:1.30,15.41)和外周血管疾病(OR=10.44,95%CI:2.94,37.03)与6个月失明相关。
要点
- GCA患者诊断后6个月至少一眼失明发生率为7.9%。
- 基线卒中使6个月失明风险升高(OR=4.47,95%CI:1.30,15.41)。
- 基线外周血管疾病使6个月失明风险显著升高(OR=10.44,95%CI:2.94,37.03)。
核心结论
- GCA患者中失明仍是常见并发症,且与已存在的血管疾病相关。
研究设计与样本
- 分析纳入血管炎诊断与分类标准研究的连续就诊患者,共433例GCA患者来自26个国家。
- 诊断后6个月通过完成血管炎损伤指数评估新发失明,采用逻辑回归分析失明与临床变量的关联。
主要发现
- 433例GCA患者中,7.9%在6个月时至少一眼失明。
- 基线卒中与6个月失明相关(OR=4.47,95%CI:1.30,15.41)。
- 基线外周血管疾病与6个月失明相关(OR=10.44,95%CI:2.94,37.03)。
临床怎么用
- 对GCA患者应关注基线卒中及外周血管疾病等血管危险因素,以识别6个月失明高风险者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Blindness is a recognized complication of GCA; however, the frequency of and risk factors for this complication have not been firmly established. The aim of this study was to examine the incidence and determinants of blindness in patients with GCA, using a large international cohort. METHODS: The analysis was conducted among subjects recruited into the Diagnosis and Classification Criteria in Vasculitis Study. The study captures consecutive patients presenting to clinic-based physicians. New-onset blindness was assessed 6 months after diagnosis by completion of the Vasculitis Damage Index. Logistic regression analysis was used to assess the association between blindness and clinical variables. RESULTS: Of 433 patients with GCA from 26 countries, 7.9% presented with blindness in at least one eye at 6 months. Risk factors identified at baseline for blindness at 6 months were identified and included prevalent stroke [odds ratio (OR) = 4.47, 95% CI: 1.30, 15.41] and peripheral vascular disease (OR = 10.44, 95% CI: 2.94, 37.03). CONCLUSION: This is the largest study to date of subjects with incident GCA and confirms that blindness remains a common complication of disease and is associated with established vascular disease. UNLABELLED: Trial registration: ClinicalTrials.gov, http://clinicaltrials.gov , NCT01066208.
引用
- Yates M, MacGregor AJ, Robson J, et al. The association of vascular risk factors with visual loss in giant cell arteritis. Rheumatology (Oxford). 2017. PMID: 27940595. doi:10.1093/rheumatology/kew397
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。